Seller record · Telehealth service

Sunlight

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the home page, the NAD+ and sermorelin pages, the help pages or the terms. The sourcing answers say only that each product is prepared by a licensed, FDA-registered compounding pharmacy.

At a glance

SunlightTelehealth service

7/8criteria passed
Price
Semaglutide $88 a month, tirzepatide $157
Sells
compounded semaglutide, compounded tirzepatide, NAD+, and 1 more
FDA letters
None on file
Visit SunlightSee all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A Washington-based telehealth platform selling compounded semaglutide and tirzepatide at one flat monthly price, plus NAD+ and sermorelin, with care from contracted medical groups. Care starts with a health intake quiz, and it names six partner pharmacies.

Operating entity GLP-1, LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSSunlight's website
S2Prescription gatingPASSSunlight's website; Sunlight's why do have to have an appointment page; Sunlight's what is your refund policy
S3Pharmacy identificationPASSSunlight's website; Sunlight's terms and conditions
S4Compounding disclosurePASSSunlight's website; Sunlight's sermorelin prescription page; Sunlight's NAD+ prescription page
S5Analytical documentationFAILSunlight's where is sermorelin sourced page; Sunlight's NAD+ page; Sunlight's terms and conditions
S6Business addressPASSSunlight's contact page; Sunlight's terms and conditions; Sunlight's privacy policy
S7Price disclosurePASSSunlight's website; Sunlight's t3 page; Sunlight's NAD+ page; Sunlight's how do cancel page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEach assessment is reviewed by a provider who makes the final prescribing decision, and the answers name the medical team, led by two physicians listed with National Provider Identifier numbers. The footer names JMP Medical and OpenLoop Health among the medical groups.Source: Sunlight's website.
S2PASSThe answers say a licensed clinician reviews the buyer's health intake quiz before any prescription, and the help pages say checkout follows the intake and that a new order can be canceled for a full refund until a clinician has reviewed it.Source: Sunlight's website; Sunlight's why do have to have an appointment page; Sunlight's what is your refund policy.
S3PASSThe answers on the home page and the terms name six partner pharmacies with telephone numbers: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills Pharmacy. No street address is printed for any of them.Source: Sunlight's website; Sunlight's terms and conditions.
S4PASSThe home page states that the compounded versions offered are not FDA-evaluated for safety, quality or effectiveness, and its footer that compounded GLP-1s are not FDA-approved. The sermorelin and NAD+ help pages say the same of those products.Source: Sunlight's website; Sunlight's sermorelin prescription page; Sunlight's NAD+ prescription page.
S5FAILNo certificate of analysis or lot document is published on the home page, the NAD+ and sermorelin pages, the help pages or the terms. The sourcing answers say only that each product is prepared by a licensed, FDA-registered compounding pharmacy.Source: Sunlight's where is sermorelin sourced page; Sunlight's NAD+ page; Sunlight's terms and conditions.
S6PASS11335 NE 122nd Way, Suite 105, Kirkland, WA 98034, printed in the footer of every page, on the contact page and beside GLP-1, LLC in the terms. The terms name Iowa law.Source: Sunlight's contact page; Sunlight's terms and conditions; Sunlight's privacy policy.
S7PASSCompounded semaglutide at $88 a month and compounded tirzepatide at $157 a month, each covering the medication, unlimited clinician visits and shipping, with the price promised to stay the same every month. A banner on every page calls the $88 figure a fall promotion, and no other semaglutide or tirzepatide price is printed. NAD+ and sermorelin start at $159 a month. Canceling after a clinician has reviewed the intake carries an $80 clinical fee.Source: Sunlight's website; Sunlight's t3 page; Sunlight's NAD+ page; Sunlight's how do cancel page.
S8PASSNo FDA warning letter names Sunlight or GLP-1, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+, sermorelin.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+

Visit Sunlight

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.